Delox

About:

Delox is designing and developing a new generation of bio-decontamination devices.

Website: https://delox.pt/

Top Investors: EIT Health, EIC Accelerator, ESA Business Applications, Portugal 2020, Bionova Capital

Description:

Delox is a spin-off of the Faculty of Sciences of the University of Lisbon, whose goals consist in the design, development, and production of a vast portfolio of automatic bio-decontamination robots. Delox developed DeloxHP, a solid formulation that safely stores and easily releases highly concentrated hydrogen peroxide vapor, which enables the development of simple, compact, cost-effective, and easy to set up bio-decontamination devices such as the Delox Box, Delox's ready-to-market solution. DeloxHP cartridges simplify and ensure the safe and convenient handling and transportation of hydrogen peroxide. Delox's target applications are laboratory equipment and environmental test chambers bio-decontamination, sterilization of medical devices, and room bio-decontamination in hospitals, pharma, and food industry.

Total Funding Amount:

1.25M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cascais, Lisboa, Portugal

Founded Date:

2018-01-01

Contact Email:

info(AT)delox.pt

Founders:

Fadhil Musa, Fernando Antunes, Joao Silva

Number of Employees:

1-10

Last Funding Date:

2024-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai